Building neurotechnology on an unshakeable foundation of clinical evidence and rigorous science.
Our research is published in high-impact, peer-reviewed journals and IEEE/Springer conferences.
Quantified results from our clinical trials and pilot studies.
Randomized, double-blind controlled trial of 20-session NeuroBand neurofeedback protocol vs. sham feedback for ADHD in children aged 8–16.
Single-arm pilot study of SIU BehaveNeu™ neurofeedback-assisted cognitive rehabilitation in post-stroke patients with mild cognitive impairment.
Prospective cohort study of continuous EEG stress monitoring in IT professionals across 6 companies over 3 months, measuring burnout biomarkers.
Randomized controlled trial of AI-driven adaptive learning triggered by EEG-detected attention levels during online coursework vs. standard e-learning.
Department of Electrical Engineering — Signal processing algorithm co-development and Ph.D. student exchange program.
Department of Neurology — Clinical validation of SIU BehaveNeu™ in neurological disorders and EEG phenotyping.
NeuroEngineering Lab — Joint research on affective BCI and multi-modal neural signal processing.
Psychiatry Department — Mental health biomarker identification using EEG for depression and anxiety.
AI research collaboration for optimizing neural network models for edge deployment on low-power microcontrollers.
Government funding body — Awarded ₹45L grant for technology development and commercialization support.